retatrutide mechanism triple agonist glp-1 gip glucagon receptor Targeting GLP-1, & GCG in Obesity and Type 2 Diabetes Research retatrutide mechanism triple agonist glp-1
Description
Common side effects include gastrointestinal symptoms such as nausea, vomiting, and diarrhea
doi: 10.1001/jama.2021.23619
Bloomgarden Z
However, additional research is needed on this possible association
What GLP-1 medications actually are GLP-1 stands for glucagon-like peptide-1
Furthermore, such a retrospective design inherently limits the identification of causal relationships, and unmeasured residual confounding variablessuch as glycemic control, hypoglycemic episodes, familial suicide history, and socioeconomic statusmay persist
